RE: HA HA22 Dec 2020 19:29
There was intrigue all around at stock market gossip generator and erstwhile Pharm2farm owner Remote Monitored Systems (RMS). Here traders were speculating on the future of the incumbent dynamic duo on the board, Paul Ryan and Trevor Brown, and whether one or both might fall on their sword. At stake is not only control of the company which they might have cede to major shareholder Dr Gareth Cave, and his private investor fanbase, but also the fate of the recent £5m fundraise / associated warrants. Interestingly enough, with the stock having been battered by all and sundry before the raise, including being flagged by RMS itself, it would be logical to assume that if the forthcoming dilution was abandoned the stock would rebound. Even if the placing remains, it might be considered the production delays / boardroom shenanigans are in the price.